Image

Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy

Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This is a multicenter, prospective, interventional clinical trial designed to evaluate and compare two intraoperative imaging modalities: laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG), for the identification of biliary anatomy in technically challenging laparoscopic cholecystectomy. All enrolled subjects will undergo both LUS and ICG during the index procedure, following a standardized sequence, in order to allow intra-subject comparison. LUS will be performed first, followed by fluorescence cholangiography prior to Calot's triangle dissection.

The primary endpoint is the successful identification of the critical junction. Secondary endpoints include visualization of individual biliary structures, time to visualization, total operative time, intraoperative and postoperative complications.

Eligibility

Inclusion Criteria:

  1. Age ≥ 18 years.
  2. Written informed consent provided.
  3. Indication for laparoscopic cholecystectomy with anticipated technical difficulty due to one or more of the following:
    • Acute cholecystitis.
    • Previous cholangitis, pancreatitis, or endoscopic retrograde cholangiopancreatography.
    • Prior upper abdominal surgery.
    • Obesity (Body Mass Index ≥ 30 kg/m²).

Exclusion Criteria:

  1. Known allergy to ICG or iodine.
  2. Pregnancy or breastfeeding.
  3. High risk of choledocholithiasis (ESGE guidelines).
  4. Thyroid disease.
  5. Suspected gallbladder malignancy.
  6. ASA class IV-V.
  7. Chronic kidney disease stage \> IIIb.
  8. Planned open cholecystectomy.

Study details
    Cholecystectomy

NCT07400237

Consorci Sanitari Integral

15 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.